Update shared on 01 Dec 2025
Fair value Increased 3.81%Analysts have raised their price target for IHH Healthcare Berhad from RM8.53 to RM8.86, citing modest improvements in fair value estimates and profit margins, despite slightly lower revenue growth assumptions.
Valuation Changes
- The Fair Value Estimate has increased slightly from MYR8.53 to MYR8.86 per share.
- The Discount Rate remains unchanged at 8.49%.
- The Revenue Growth assumption has decreased from 8.96% to 8.09%.
- The Net Profit Margin forecast has increased modestly from 8.33% to 8.48%.
- The future P/E ratio has moved up from 36.10x to 36.37x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.